prof. MUDr. Tomáš Büchler, Ph.D.

2024

• Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy

  BÜCHLER Tomáš POPRACH Alexandr

  Article in Periodical

  Targeted Oncology, year: 2024, volume: 19, edition: 2, DOI

2023

• 2. ročník PROSTAFORUM 2023

  KOUDELKOVÁ Marcela MÁJEK Ondřej BABJUK Marek ZACHOVAL Roman FERDA Jiří SPRINGER Drahomíra BÜCHLER Tomáš TRNKOVÁ Markéta ŠONKA Petr HERBER Otto

  Conference

  Year: 2023, type: Conference

2021

• Incidence, Mortality and Survival of Bladder Neoplasms in the Czech Republic in 1977–2017: Time Trend Analysis

  PEHALOVÁ Lucie KREJČÍ Denisa BÜCHLER Tomáš ŠNAJDROVÁ Lenka DUŠEK Ladislav

  Article in Periodical

  Časopis Klinická onkologie, year: 2021, volume: 34, edition: 6, DOI

2020

• Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients

  NOVAKOVA-JIRESOVA Alena KOPECKOVA Katerina BOUBLIKOVA Ludmila CHLOUPKOVÁ Renata MELICHAR Bohuslav PETRUZELKA Lubos FINEK Jindrich FIALA Ondrej GRELL Peter BATKO Stanislav LINKE Zdenek KISS Igor PRAUSOVA Jana BÜCHLER Tomáš

  Article in Periodical

  CANCER MANAGEMENT AND RESEARCH, year: 2020, volume: 12, edition: 2020, DOI

• Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib

  BÜCHLER Tomáš KOPECKA Marie ZEMANKOVA Anezka WIESNEROVA Marketa STRECKOVA Marketa ROZSYPALOVA Aneta MELICHAR Bohuslav POPRACH Alexandr RICHTER Igor

  Article in Periodical

  Targeted Oncology, year: 2020, volume: 15, edition: 5, DOI

2019

• Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients

  FIALA Ondrej OSTASOV Pavel SOREJS Ondrej LISKA Vaclav BÜCHLER Tomáš POPRACH Alexandr FINEK Jindrich

  Article in Periodical

  Cancers, year: 2019, volume: 11, edition: 12, DOI

• Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC

  HEBART Holger KIEHL Michael TOMÁŠEK Jiří CSOSZI Tibor KOUKAKIS Reija KAFATOS George KUHN Anja BJORKLOF Katja DEMONTY Gaston BÜCHLER Tomáš

  Article in Periodical

  ADVANCES IN THERAPY, year: 2019, volume: 36, edition: 3, DOI

• Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database

  POPRACH Alexandr RUMANOVÁ Kristína LAKOMÝ Radek CHLOUPKOVÁ Renata STANÍK Michal POKRIVČÁK Tomáš KISS Igor SLABÝ Ondřej STUDENTOVA Hana MELICHAR Bohuslav JURÁČEK Jaroslav FIALA Ondrej KOPECKY Jindrich KOPECKOVA Katerina ZEMANOVA Milada BÜCHLER Tomáš

  Article in Periodical

  UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, year: 2019, volume: 37, edition: 4, DOI

2017

• Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma

  FEDORKO Michal JURÁČEK Jaroslav STANÍK Michal SVOBODA Marek POPRACH Alexandr BÜCHLER Tomáš PACÍK Dalibor DOLEŽEL Jan SLABÝ Ondřej

  Article in Periodical

  Biochemia Medica, year: 2017, volume: 27, edition: 2, DOI

• Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry

  KOPEČKOVÁ Kateřina BÜCHLER Tomáš BORTLÍČEK Zbyněk HEJDUK Karel CHLOUPKOVÁ Renata MELICHAR Bohuslav POKORNÁ Petra TOMÁŠEK Jiří LINKE Zdeněk PETRUŽELKA Luboš KISS Igor PRAUSOVÁ Jana

  Article in Periodical

  Targeted Oncology, year: 2017, volume: 12, edition: 1, DOI